NCT05623085

Brief Summary

The aim of this study is to compare the effects of aerobic exercise and yoga exercises on menstrual pain parameters (pain severity and duration, analgesic usage), uterine artery blood flow, menstrual stress level, physical fitness, anxiety/depressive symptom level, quality of life and sleep quality in individuals with primary dysmenorrhea. This study is a prospective, parallel group, randomized study. Three days a week for eight weeks, the participants in this study will receive individualized yoga and aerobic exercise. In the literature, there are no studies comparing the effectiveness of aerobic exercise and yoga in the management of PD, which is a public health problem that seriously affects women's lives. Especially when aerobic exercise and yoga exercises are considered, there is no study on how much the features such as uterine artery blood flow and physical fitness sub-parameters have changed with these two commonly used exercise types separately in the management of PD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 31, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

October 31, 2022

Completed
21 days until next milestone

First Posted

Study publicly available on registry

November 21, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 4, 2023

Completed
Last Updated

November 15, 2024

Status Verified

November 1, 2024

Enrollment Period

10 months

First QC Date

October 31, 2022

Last Update Submit

November 13, 2024

Conditions

Keywords

Menstrual PainUterine BleedingYoga exerciseAerobic exerciseDysmenorrhea

Outcome Measures

Primary Outcomes (1)

  • Menstrual pain severity

    As primary outcome measures, the highest menstrual pain severity perceived by the participants in their last menstruation and the average of the pain severity in the first 3 days of their menstruation will be evaluated. A 10-cm VAS from zero (no pain at all) to 10 (the worst pain I have ever felt) will be used to determine the severity of menstrual pain. Individuals will be asked to mark the severity of pain they felt in the first 3 days of their last menstruation on 3 separate VAS lines.

    Change in severity of menstrual pain from baseline up to end of 8th week, 3rd month, and 6th month.

Secondary Outcomes (17)

  • Uterine artery blood flow

    Change in uterine artery blood flow from baseline up to end of 8th week.

  • Body mass index

    Change in body mass index from baseline up to end of 8th week, 3rd month, and 6th month.

  • body fat percentage

    Change in body fat percentage from baseline up to end of 8th week, 3rd month, and 6th month.

  • body fat amount

    Change in body fat amount from baseline up to end of 8th week, 3rd month, and 6th month.

  • lean body weight ratio

    Change in lean body weight ratio from baseline up to end of 8th week, 3rd month, and 6th month.

  • +12 more secondary outcomes

Study Arms (2)

Aerobic Exercise

EXPERIMENTAL

Aerobic exercise group with 8 weeks of individualized exercise according to the Karvonen protocol (heart rate reserve percentage-% HR). Exercise training will be 30 minutes at 50% of HR between weeks 0-2, 45 minutes at 50% of HR between weeks 2-4, 45 minutes at 60% of HR between weeks 4-6 and 6-8 weeks It will be done on the treadmill 3 days a week, for 60 minutes at 60% of HR between weeks. The treadmill speed will be adjusted during exercise to maintain the set target heart rate level.

Other: Aerobic exercise

Yoga Exercise

ACTIVE COMPARATOR

Yoga exercise group with 8 weeks of individualized exercise program. Exercise training will be done 3 days a week. The duration of the exercise will be adjusted to be the same as the aerobic exercise group.

Other: Yoga exercise

Interventions

Individuals in this group will be given 8-week individualized exercise according to the Karvonen protocol (heart rate reserve percentage-% HR). Exercise training will be 30 minutes at 50% of HR between weeks 0-2, 45 minutes at 50% of HR between weeks 2-4, 45 minutes at 60% of HR between weeks 4-6 and 6-8 weeks It will be done on the treadmill 3 days a week, for 60 minutes at 60% of HR between weeks. The treadmill speed will be adjusted during exercise to maintain the set target heart rate level.

Aerobic Exercise

Individuals in this group will be given 8-week individualized yoga exercise including stretching, relaxing, strength training. Exercise training will be done 3 days a week. The duration of the exercise will be adjusted to be the same as the aerobic exercise group.

Yoga Exercise

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals who do not have any known disease (systemic, metabolic, etc.),
  • No complaints of acute or chronic pain other than dysmenorrhea,
  • Meeting the primary dysmenorrhea criteria outlined in the Primary Dysmenorrhea Consensus Guide (onset of menstrual pain 6-24 months after menarche, menstrual pain lasting 8-72 hours, and the most severe pain felt on the 1st or 2nd day of menstruation),
  • Have a regular menstrual cycle (28± 7 days),
  • The severity of menstrual pain in the last 6 months is ≥ 4 cm according to the Visual Analogue Scale,
  • years and over,
  • Nulligravid (unborn)
  • Volunteer female individuals who gave consent to participate in the study

You may not qualify if:

  • Individuals undergoing pelvic surgery,
  • Having a history and/or finding of secondary dysmenorrhea,
  • Receiving alternative treatment,
  • Using intrauterine contraceptive device or birth control pill,
  • Individuals with situations where exercise is contraindicated (answering yes to any of the 7 questions on the exercise readiness scale),
  • Not complying with the requirements of the research protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gamze Nalan Çinar

Ankara, 06100, Turkey (Türkiye)

Location

Related Publications (9)

  • Wickstrom K, Edelstam G. Minimal clinically important difference for pain on the VAS scale and the relation to quality of life in women with endometriosis. Sex Reprod Healthc. 2017 Oct;13:35-40. doi: 10.1016/j.srhc.2017.05.004. Epub 2017 May 25.

    PMID: 28844356BACKGROUND
  • Enright PL. The six-minute walk test. Respir Care. 2003 Aug;48(8):783-5.

    PMID: 12890299BACKGROUND
  • Guimaraes AC, Vaz MA, De Campos MI, Marantes R. The contribution of the rectus abdominis and rectus femoris in twelve selected abdominal exercises. An electromyographic study. J Sports Med Phys Fitness. 1991 Jun;31(2):222-30.

    PMID: 1836517BACKGROUND
  • Bianco A, Lupo C, Alesi M, Spina S, Raccuglia M, Thomas E, Paoli A, Palma A. The sit up test to exhaustion as a test for muscular endurance evaluation. Springerplus. 2015 Jul 2;4:309. doi: 10.1186/s40064-015-1023-6. eCollection 2015.

    PMID: 26155448BACKGROUND
  • Arnold CM, Warkentin KD, Chilibeck PD, Magnus CR. The reliability and validity of handheld dynamometry for the measurement of lower-extremity muscle strength in older adults. J Strength Cond Res. 2010 Mar;24(3):815-24. doi: 10.1519/JSC.0b013e3181aa36b8.

    PMID: 19661831BACKGROUND
  • Moos RH. The development of a menstrual distress questionnaire. Psychosom Med. 1968 Nov-Dec;30(6):853-67. doi: 10.1097/00006842-196811000-00006. No abstract available.

    PMID: 5749738BACKGROUND
  • Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995 Mar;33(3):335-43. doi: 10.1016/0005-7967(94)00075-u.

    PMID: 7726811BACKGROUND
  • Levine DW, Kripke DF, Kaplan RM, Lewis MA, Naughton MJ, Bowen DJ, Shumaker SA. Reliability and validity of the Women's Health Initiative Insomnia Rating Scale. Psychol Assess. 2003 Jun;15(2):137-48. doi: 10.1037/1040-3590.15.2.137.

    PMID: 12847774BACKGROUND
  • Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989 Dec;10(4):407-15. doi: 10.1016/0197-2456(89)90005-6.

    PMID: 2691207BACKGROUND

MeSH Terms

Conditions

DysmenorrheaUterine Hemorrhage

Interventions

Exercise

Condition Hierarchy (Ancestors)

Menstruation DisturbancesPathologic ProcessesPathological Conditions, Signs and SymptomsPelvic PainPainNeurologic ManifestationsSigns and SymptomsUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesHemorrhage

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Serap Özgül, Prof

    Hacettepe University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof.

Study Record Dates

First Submitted

October 31, 2022

First Posted

November 21, 2022

Study Start

October 31, 2022

Primary Completion

September 1, 2023

Study Completion

December 4, 2023

Last Updated

November 15, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations